AccuraSee IOPCL Scored High at AECOS

AECOS summer 2022

Kevin Cady, OnPoint Vision president, was honored to present at the American-European Congress of Ophthalmic Surgeons (AECOS), hosted at the beautiful St. Regis Resort, Deer Valley, Utah. The AccuraSee IOPCL (AKA: CadyLens) scored high among the physician attendees.

Cady was humbled by the overall enthusiastic response and congratulatory messages received from many of the Key Opinion Leaders in the industry.

“This was a most memorable meeting for me to say the least. I am most grateful to my family, friends and colleagues for all your support.”

.
Previous slide
Next slide

OnPoint Vision Sees Clear Road Ahead

December 12, 2023

OnPoint Vision has developed a 4.5 millimeter lens to help treat macular degeneration. The Food and Drug Administration initially accepted Kevin Cady’s proposal for an implantable lens to correct vision after cataract surgery. Then the

Read More »

OnPoint Vision, Inc.™
6A Liberty Street, Suite 100
Aliso Viejo, CA 92656

email: info@onpoint-vision.com

phone: (949) 688-0660

KEVIN CADY
President & CEO

Kevin Cady is the CEO and Founder of OnPoint Vision™, a refractive company that designs, develops & manufactures intraocular lens implants, most specifically the AccuraSee™ Intraocular Pseudophakic Contact Lens (AKA: CadyLens) designed to fine-tune the refractive error of the pseudophakic eye as well as deliver vision recovery for patients who have experienced a decline in vision due to age-related retinal pathologies.  Prior to forming OnPoint Vision™, Mr. Cady joined Refocus Group in 2015 as Vice President of Marketing & Business Development. From 2011 to 2014, Mr. Cady was the Regional Business Director for WaveTec Vision Systems, where he was responsible for the marketplace expansion of the Optiwave Refractive Analysis (ORA) system to ophthalmic surgeons. Prior to joining WaveTec Vision Systems, Mr. Cady was the Area Vice President of Sales for Bausch Lomb Surgical, after the company acquired Eyeonics. Mr. Cady has over 30 years in the ophthalmic industry theatre with extensive knowledge and experience in both the development of ophthalmic pharmacologic agents and medical device product line.

Mr. Cady has a Bachelor of Science Degree in Economics from Illinois State University. He is credentialed with over 35 patents worldwide with the  invention of the CadyLens, an Intraocular Pseudophakic Contact Lens (IOPCL) as well as related surgical instruments and medical devices.